HIGHLIGHTS
- who: Nengzhi Pang and colleagues from the School of Public Health, Yat-sen University, Guangzhou, China have published the Article: Nicotinamide Adenine Dinucleotide Precursor Suppresses Hepatocellular Cancer Progression in Mice, in the Journal: Nutrients 2023, 1447 of 12/03/2023
- what: Targeting (NAD) metabolism has emerged as a promising anti-cancer strategy; the authors aimed to explore the health benefits of boosting NAD levels with riboside (NR) on hepatocellular carcinoma (HCC). The authors examined NAD provides the primary reducing power to eliminate ROS . The authors examined NADP in human samples. in HCC tissues found NAD . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.